Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesDec 18, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 4, 2017View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventNov 28, 2017View HTMLDownload DOCDownload PDFDownload XLS
CT ORDERConfidential treatment orderNov 17, 2017View HTMLDownload DOCDownload PDF
10-Q/AAmendment to a previously filed 10-QNov 13, 2017View HTMLDownload DOCDownload PDFDownload XLS
10-QQuarterly report which provides a continuing view of a company's financial positionOct 31, 2017View HTMLDownload DOCDownload PDFDownload XLSView XBRLDownload XBRL
8-KReport of unscheduled material events or corporate eventOct 26, 2017View HTMLDownload DOCDownload PDFDownload XLS
4/AAmendment to a previously filed 4Oct 13, 2017View HTMLDownload DOCDownload PDF
4/AAmendment to a previously filed 4Oct 13, 2017View HTMLDownload DOCDownload PDF
4/AAmendment to a previously filed 4Oct 13, 2017View HTMLDownload DOCDownload PDF
4/AAmendment to a previously filed 4Oct 13, 2017View HTMLDownload DOCDownload PDF
4/AAmendment to a previously filed 4Oct 13, 2017View HTMLDownload DOCDownload PDF
3Initial filing by director officer or owner of more than ten percent.Oct 3, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesOct 3, 2017View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventOct 3, 2017View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesOct 2, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 26, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 19, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 19, 2017View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventAug 11, 2017View HTMLDownload DOCDownload PDFDownload XLS
424B5Form of prospectus disclosing information facts events covered in both forms 424B2 424B3Aug 9, 2017View HTMLDownload DOCDownload PDFDownload XLS
FWPFree Writing ProspectusAug 9, 2017View HTMLDownload DOCDownload PDFDownload XLS
424B5Form of prospectus disclosing information facts events covered in both forms 424B2 424B3Aug 8, 2017View HTMLDownload DOCDownload PDFDownload XLS
305B2Initial statement filed pursuant to the Trust Indenture ActAug 8, 2017View HTMLDownload DOCDownload PDFDownload XLS
10-QQuarterly report which provides a continuing view of a company's financial positionAug 2, 2017View HTMLDownload DOCDownload PDFDownload XLSView XBRLDownload XBRL
1-25      26-50      51-75      76-100      101-125      126-132

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information